First Time Loading...

Progenity Inc
NASDAQ:PROG

Watchlist Manager
Progenity Inc Logo
Progenity Inc
NASDAQ:PROG
Watchlist
Price: 0.69 USD 0.01%
Updated: Apr 29, 2024

Profitability Summary

37/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37/100
Profitability
Score
37/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Progenity Inc

Revenue
1.2m USD
Operating Expenses
-107.5m USD
Operating Income
-106.3m USD
Other Expenses
-122.7m USD
Net Income
-229m USD

Margins Comparison
Progenity Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Progenity Inc
NASDAQ:PROG
127.1m USD
-9 007%
-19 403%
US
Cigna Corp
NYSE:CI
104.7B USD
5%
3%
US
Cigna Group
XMUN:CGN
96.6B EUR
5%
3%
US
CVS Health Corp
NYSE:CVS
86.9B USD
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
22B EUR
7%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
9%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR
5%
-3%
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD
14%
9%
US
DaVita Inc
NYSE:DVA
12.3B USD
13%
6%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
7%
3%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
-22%
-24%
Country US
Market Cap 127.1m USD
Operating Margin
-9 007%
Net Margin
-19 403%
Country US
Market Cap 104.7B USD
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 96.6B EUR
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 86.9B USD
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 22B EUR
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 16.9B USD
Operating Margin
9%
Net Margin
4%
Country DE
Market Cap 15.6B EUR
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 15.7B USD
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 12.3B USD
Operating Margin
13%
Net Margin
6%
Country DE
Market Cap 11.4B EUR
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 9.5B USD
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Progenity Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Progenity Inc
NASDAQ:PROG
127.1m USD
209%
-213%
-240%
-344%
US
Cigna Corp
NYSE:CI
104.7B USD
11%
3%
9%
7%
US
Cigna Group
XMUN:CGN
96.6B EUR
11%
3%
9%
7%
US
CVS Health Corp
NYSE:CVS
86.9B USD
11%
3%
9%
6%
DE
Fresenius Medical Care AG
XMUN:FME
22B EUR
4%
1%
4%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
5%
2%
7%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR
-3%
-1%
2%
1%
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD
14%
6%
11%
8%
US
DaVita Inc
NYSE:DVA
12.3B USD
78%
4%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
4%
1%
4%
3%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country US
Market Cap 127.1m USD
ROE
209%
ROA
-213%
ROCE
-240%
ROIC
-344%
Country US
Market Cap 104.7B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 96.6B EUR
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 86.9B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
6%
Country DE
Market Cap 22B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 16.9B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 15.6B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 15.7B USD
ROE
14%
ROA
6%
ROCE
11%
ROIC
8%
Country US
Market Cap 12.3B USD
ROE
78%
ROA
4%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.4B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More